Tumors

Amit Sa'ar, head of IDF Research Department on October 7, dead at 47

Sa’ar recently underwent special treatment in the US, but his condition deteriorated, prompting senior members of the intelligence community to visit him over the past week.

 Brig.-Gen. Amit Sa'ar speaks at a conference of the Gazit Institute in Tel Aviv, November 5, 2022
An US-Israeli teen who was arrested in Israel on suspicion of making bomb threats against Jewish community centers in the United States, Australia and New Zealand is seen at a remand hearing at Magistrate's Court in Rishon Lezion, Israel on March 23, 2017

Norway to extradite ‘Ashkelon hacker’ Michael Kadar to US despite severe mental health concerns

An ultrasound image of a tumor seen on a fetus (illustrative)

Israeli medical team removes 'largest-ever' facial tumor found on fetus

Blood collection tubes pictured during the annual blood collection campaign 'Bloedserieus', organised by the Red Cross Flanders, on Monday 12 May 2025, at Training centre ZoWe Campus Brugge.

Health Ministry confirms BRCA test fault isolated to two cases, nationwide review clear


The full Monty: When dog and owner are both battling cancer - opinion

For both of us, a sinister countdown had started.

 Celebrating Monty on one of his anniversaries.

Netanyahu’s health report: Cancer-free, pacemaker operational, infection persists

Prime Minister Netanyahu’s doctors released a medical report detailing the procedures he has undergone and his latest blood tests.

 Prime Minister Benjamin Netanyahu attends the Tel Aviv District Court. December 24, 2024.

Mystery solved: Researchers find how tumor cells die

Scientists at Children’s Medical Research Institute (CMRI) have solved a remarkable puzzle in cancer research: why cells die in different ways following radiotherapy.

 Chromosomes from cancer cells with DNA stained blue, telomeres stained green, and centromeres stained pink.

Severe malfunction in cancer diagnosis device: Patients may have received incorrect treatment

Roche reported a malfunction in several devices for diagnosing cancerous tumors to the Health Ministry, which may have led to incorrect diagnoses and inappropriate treatment for cancer patients.

 A 3D rendering of cancer cells (Illustrative).

As new findings about tumors and glucose starvation have opened a therapeutic window

It is a novel approach to brain cancer based on a decade of research in his lab.

 Illustration for demonstration of 3D printing of a tumor in a brain Microenvironment according to a computed 3D model.

Extracellular bubbles in the heart muscle may cause higher cancer risk, new study shows

Researchers at Tel Aviv University (TAU) and at Sheba Medical Center at Tel Hashomer have found a mechanism that is responsible for the increased risk of getting cancer among heart disease patients.

 Monitor your symptoms carefully if you're at risk of a heart attack

Technion scientists predict the efficacy of novel therapies in cancer

The researchers created a tool to predict which patients will respond to this therapy based on this therapy that shows the importance of metabolism in the tumor microenvironment.

 Professor Keren Yizhak. February 2, 2024.

Two cancer treatments, carefully selected, can be much better than one

An AI tool based on a new concept called “meta-synergy” helps find more powerful drug combinations.

 Prof. Yosi Shamay (right) and doctoral student Dana Meron Azagury at the Controlled Release conference.

The challenges and rewards of rehabilitation - opinion

Imagine yourselves at the age of 15, with a million plans for the future, but facing a shocking reality where those plans were crumbling around them.

 RECOVERY CAN be a walk in the park.

Shocking discovery: Man tests positive on pregnancy test, leaves doctor astonished

A 42-year-old man's severe abdominal pain leads to a surprising positive pregnancy test, a shocking diagnosis, and many medical questions.


Israel, China team hopes to crack cure for advanced-stage solid tumors

Israel's Enlivex Therapeutics and China's BeiGene teamed up to study combining macrophage reprogramming and an anti-PD-1 immune checkpoint inhibitor.

 A doctor prepares to administer Allocetra. (Illustrative photo)